Amends TCA Title 20 and Title 33.

Tennessee HB0491 amends the Tennessee Code Annotated (TCA) Titles 20 and 33 to expand the list of entities from which the Attorney General can release claims related to opioid settlements, now including Amneal Pharmaceuticals, Hikma Pharmaceuticals, and Sun Pharmaceutical Industries. The bill also mandates that proceeds from settlements with these companies, along with previously included entities, be allocated for opioid abatement efforts, with 35% going to participating counties and 65% for statewide or local remediation purposes. Key provisions include the addition of new entities for claim releases and the inclusion of settlement proceeds from these entities in the existing disbursement framework.